These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In vitro anti-Candida activity of certain new 3-(1H-imidazol-1-yl)propan-1-one oxime esters. Attia MI; Zakaria AS; Almutairi MS; Ghoneim SW Molecules; 2013 Sep; 18(10):12208-21. PubMed ID: 24084023 [TBL] [Abstract][Full Text] [Related]
3. Synthesis, Optimization, Antifungal Activity, Selectivity, and CYP51 Binding of New 2-Aryl-3-azolyl-1-indolyl-propan-2-ols. Lebouvier N; Pagniez F; Na YM; Shi D; Pinson P; Marchivie M; Guillon J; Hakki T; Bernhardt R; Yee SW; Simons C; Lézé MP; Hartmann RW; Mularoni A; Le Baut G; Krimm I; Abagyan R; Le Pape P; Le Borgne M Pharmaceuticals (Basel); 2020 Aug; 13(8):. PubMed ID: 32784450 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of novel 1-(1H-1,2,4-triazol-1-yl)-2-(2,4-difluorophenyl)-3-[(4-substitutedphenyl)-piperazin-1-yl]-propan-2-ols as antifungal agents. Sun QY; Zhang WN; Xu JM; Cao YB; Wu QY; Zhang DZ; Liu CM; Yu SC; Jiang YY Eur J Med Chem; 2007 Aug; 42(8):1151-7. PubMed ID: 17184885 [TBL] [Abstract][Full Text] [Related]
5. Antifungal agents. 11. N-substituted derivatives of 1-[(aryl)(4-aryl-1H-pyrrol-3-yl)methyl]-1H-imidazole: synthesis, anti-Candida activity, and QSAR studies. Di Santo R; Tafi A; Costi R; Botta M; Artico M; Corelli F; Forte M; Caporuscio F; Angiolella L; Palamara AT J Med Chem; 2005 Aug; 48(16):5140-53. PubMed ID: 16078834 [TBL] [Abstract][Full Text] [Related]
6. Candida and candidaemia. Susceptibility and epidemiology. Arendrup MC Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and antimicrobial activity of 3-arylamino-1-chloropropan-2-ols. Prasad AK; Kumar P; Dhawan A; Chhillar AK; Sharma D; Yadav V; Kumar M; Jha HN; Olsen CE; Sharma GL; Parmar VS Bioorg Med Chem Lett; 2008 Mar; 18(6):2156-61. PubMed ID: 18281215 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and antifungal activity of a new series of 2-(1H-imidazol-1-yl)-1-phenylethanol derivatives. De Vita D; Scipione L; Tortorella S; Mellini P; Di Rienzo B; Simonetti G; D'Auria FD; Panella S; Cirilli R; Di Santo R; Palamara AT Eur J Med Chem; 2012 Mar; 49():334-42. PubMed ID: 22321993 [TBL] [Abstract][Full Text] [Related]
9. Antifungal agents. VI. In vitro antifungal activities of halobenzoyl esters of cis- and trans-[2-(1,1'-biphenyl-4-yl)-2-(1H-imidazol-1-ylmethyl)-1,3- dioxolan-4-yl]carbinols. Stefancich G; Silvestri R; Pagnozzi E; Artico M; Retico A; Apuzzo G; Simonetti N Farmaco; 1993 Aug; 48(8):1103-12. PubMed ID: 8216672 [TBL] [Abstract][Full Text] [Related]
10. Discovery of new azoles with potent activity against Candida spp. and Candida albicans biofilms through virtual screening. Sari S; Kart D; Öztürk N; Kaynak FB; Gencel M; Taşkor G; Karakurt A; Saraç S; Eşsiz Ş; Dalkara S Eur J Med Chem; 2019 Oct; 179():634-648. PubMed ID: 31279296 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and anti-candida potential of certain novel 1-[(3-Substituted-3-phenyl)propyl]-1H-imidazoles. Aboul-Enein MN; El-Azzouny AA; Attia MI; Saleh OA; Kansoh AL Arch Pharm (Weinheim); 2011 Dec; 344(12):794-801. PubMed ID: 21987482 [TBL] [Abstract][Full Text] [Related]
12. Antifungal agents. 10. New derivatives of 1-[(aryl)[4-aryl-1H-pyrrol-3-yl]methyl]-1H-imidazole, synthesis, anti-candida activity, and quantitative structure-analysis relationship studies. Tafi A; Costi R; Botta M; Di Santo R; Corelli F; Massa S; Ciacci A; Manetti F; Artico M J Med Chem; 2002 Jun; 45(13):2720-32. PubMed ID: 12061875 [TBL] [Abstract][Full Text] [Related]
13. Elucidating the structural basis for the enhanced antifungal activity of amide derivative against Kechi EL; Ubah CB; Runde M; Owen AE; Godfrey OC; Agurokpon DC; Odey MO; Edet UO; Ekpong BO; Iyam SO; Benjamin I; Sampathkumar G In Silico Pharmacol; 2024; 12(1):48. PubMed ID: 38828443 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and molecular docking studies of novel triazole as antifungal agent. Chai X; Zhang J; Cao Y; Zou Y; Wu Q; Zhang D; Jiang Y; Sun Q Eur J Med Chem; 2011 Jul; 46(7):3167-76. PubMed ID: 21531485 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, anti-microbial activity, cytotoxicity of some novel substituted (5-(3-(1H-benzo[d]imidazol-2-yl)-4-hydroxybenzyl)benzofuran-2-yl)(phenyl)methanone analogs. Shankar B; Jalapathi P; Saikrishna B; Perugu S; Manga V Chem Cent J; 2018 Jan; 12(1):1. PubMed ID: 29318401 [TBL] [Abstract][Full Text] [Related]
16. Antifungal agents. 10. Synthesis and antifungal activities of aryl-(1H-imidazol-1-yl)-(isoquinolin-1-yl) methane derivatives. Silvestri R; Pagnozzi E; Troccoli F; Stefancich G; Massa S; Apuzzo G; Perazzi ME; Artico M; Simonetti G Farmaco; 1995 Apr; 50(4):227-38. PubMed ID: 7669167 [TBL] [Abstract][Full Text] [Related]
17. Antifungal agents. 9. 3-Aryl-4-[alpha-(1H-imidazol-1-yl)arylmethyl]pyrroles: a new class of potent anti-Candida agents. Artico M; Di Santo R; Costi R; Massa S; Retico A; Artico M; Apuzzo G; Simonetti G; Strippoli V J Med Chem; 1995 Oct; 38(21):4223-33. PubMed ID: 7473549 [TBL] [Abstract][Full Text] [Related]
18. 8-(1H-imidazol-1-yl)-7-nitro-4(5H)-imidazo[1,2-alpha]quinoxalinone and related compounds: synthesis and structure-activity relationships for the AMPA-type non-NMDA receptor. Ohmori J; Shimizu-Sasamata M; Okada M; Sakamoto S J Med Chem; 1997 Jun; 40(13):2053-63. PubMed ID: 9207947 [TBL] [Abstract][Full Text] [Related]
19. Optically active antifungal azoles: synthesis and antifungal activity of (2R,3S)-2-(2,4-difluorophenyl)-3-(5-[2-[4-aryl-piperazin-1-yl]-ethyl]-tetrazol-2-yl/1-yl)-1-[1,2,4]-triazol-1-yl-butan-2-ol. Upadhayaya RS; Sinha N; Jain S; Kishore N; Chandra R; Arora SK Bioorg Med Chem; 2004 May; 12(9):2225-38. PubMed ID: 15080922 [TBL] [Abstract][Full Text] [Related]
20. Synthesis of new isoxazoles and dihydroisoxazoles and in vitro evaluation of their antifungal activity. Chevreuil F; Landreau A; Séraphin D; Larcher G; Mallet S; Bouchara JP; Richomme P J Enzyme Inhib Med Chem; 2007 Oct; 22(5):563-9. PubMed ID: 18035824 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]